The indispensible 2-volume guide to the companies that are shaping this critical area.
The importance of drug delivery technology grows ever more acute and commercial, and industry interest is continuing to build. The benefits to patients can be seen through improved medical outcomes, while the pharmaceutical industry is able to bring new products to market and extend patent protection through novel delivery regimes, and bring new therapies to the market that would previously have been impossible.
Consequently, the drug delivery sector has evolved from being simply a part of the pharmaceutical production process to a driving force for innovation and profits. As a result, developers of drug delivery products and technology have benefited from significant attention from customers and investors alike, and merger and acquisition activity is notable.
Who’s Developing What in Drug Delivery? is a new 680+ page management report (expanded 4th edition, published October 2008) that provides comprehensive analysis of 135 leading players in the drug delivery field.
“By 2015 sales of products using advanced drug delivery technology assessed could exceed US$43 billion.”
Key features and benefits...
Detailed review of 134 leading companies in the field
Comprehensive coverage of each company’s technology focus, products, R&D and deals
International coverage - companies from across the world reviewed
All major drug-delivery technologies covered including:
- Controlled-release
- Nucleic acid
- Nano-enabled
- Targeted
Please note, this file is delivered as a Zip file.
Additional Information
Who’s Developing What in Drug Delivery?
Comprehensive analysis of the companies driving growth.
While pharmaceutical sales have continued to rise steadily, generating over US$600 billion in 2007, the global drug delivery market has undergone rapid growth from an estimated US$26 billion in 2000 to approximately US$67 billion in 2006. This market has been driven by a number of factors including:
Patent expiration of leading brands forcing the pharmaceutical industry to evaluate ways to maximise product life-cycles through new formulations, combinations and repositioning;
Advances in new delivery technology (microencapsulation and nanotechnology); and
The development and cost-effective manufacture of new delivery materials (dendrimers, lipid formulations and biodegradable polymers).
Within this market there are a number of areas of advanced drug delivery which have attracted the attention of the pharmaceutical industry and the investment community. The dramatic growth of the sector is reflected in the evolution of an array of delivery vehicles and hybrid platforms that are increasingly being used to deliver approved and novel therapeutic agents.
Understand the corporate landscape...
For researchers, drug developers, commercial management and investors the need to understand the strengths, weaknesses, products and position of the drug-delivery companies that are leading the way is critical. This new report - issued by the publishers of Drug Delivery Insight - has become the essential resource for assessing drug-delivery companies worldwide.
Important areas covered for each company analysed include:
Company Overview & Technology Focus
Key Personnel
Competition & Competing Products
Key Milestones
Products/Technologies
R&D & Research Strategy
Key Agreements & Alliances
Financial Data (if available)
Comprehensive Contact Details
Use the report for...
Assessing the strengths and weaknesses of leading drug delivery companies
Knowing who is working with whom, and on what
Identifying licensing and collaboration partners
Understanding the main research approaches being pursued
“Few sectors of the pharmaceutical industry will enjoy such a high level of growth in the future”
Leading and emerging companies covered...
3M DDS
Abraxis Bioscience
Access Pharmaceuticals
Acusphere
Acrux
Akela Pharma
Alizyme
Alkermes
AlphaRx
AlphaVax
Altea Therapeutics
ALZA Corporation
Antares Pharma
AP Pharma
Aradigm Corporation
Avidimer Therapeutics
Baxa Corporation
Baxter International
Bentley Pharmaceuticals
BioDelivery Sciences International
Bioject Medical Technologies
BioSante Pharmaceuticals
Biovail Corporation
Calando Pharmaceuticals
Camurus AB
Cardinal Health
Cephalon
Cipher Pharmaceuticals
Columbia Laboratories
Consort Medical
Copernicus Therapeutics
CPEX Pharmaceuticals
Critical Therapeutics
CyDex Pharmaceuticals DebioPharm
Delcath Systems
DelSite Biotechnologies
DepoMed
Diatos
DOR BioPharma
Durect Corporation
DUSA Pharmaceuticals
Echo Therapeutics
Elan
Elite Pharmaceticals
Emisphere Technologies
Encap Drug Delivery
Endo Pharmaceuticals
Endocyte
Endovasc
Enzon
Ethypharm
Eurand
Expression Genetics
Fertin Pharma
Flamel Technologies
FzioMed
Generex Biotechnology Corporation
Glycologic
Hospira
ImaRx Therapeutics
Immunogen
Impax Laboratories
Indevus Pharmaceuticals
Innocoll Technologies
Inovio Biomedical
InSite Vision
Intercell Intranasal Therapeutics
KV Pharmaceutical
Labopharm
Lavipharm Group
Light Sciences Corporation
MacroChem Corporation
MaxCyte
MDRNA
MedImmune
Meldex International
Milestone Scientific
Mirus Bio Corporation
Moog Medical Devices
Nanobiotix
NanoMaterials Technology
NanoBio Corporation
NanoBioMagnetics
NanoCarrier
Nanotherapeutics
Nano Interface Technology
Nano S Biotechnology
Nanotechnology Victoria
Nektar Therapeutics
NeoPharm
Neurotech
NexMed
Norwood Abbey
NovaDel Pharma
Novagali Pharma
Novavax
Noven Pharmaceuticals
Novosom
Oakwood Laboratories
OctoPlus Orexo
Oriel Therapeutics
Otsuka
PCI Biotech
Penwest Pharmaceuticals
Phoqus Group
Phosphagenics Ltd
PhotoCure
Point Biomedical Corporation
Protherics
pSivida
QLT
Quest PharmaTech
Scolr Pharma
Seattle Generics
Silinece Therapeutics
Skinvisible
SkyePharma
Spherics
Starpharma
Supratek Pharma
Syntonix Pharmaceuticals
Tekmira Pharmaceuticals
Telesso Technologies
TransPharma Medical
Urigen Pharmaceuticals
Vectura
Vival
Vivus
Zogenix
Zosano Pharma
(0 items)
